Brajendra Tripathi: Keeping an eye out for translational research

Area of Science:

• Molecular Biology
• Oncology
• Cell Signaling

Background:

• The tumor suppressor gene deleted in liver cancer 1 (DLC1) plays a critical role in regulating cell growth and preventing tumor formation.
• Oncogenic kinases are frequently dysregulated in cancer and can promote uncontrolled cell proliferation.
• Understanding the interplay between DLC1 and oncogenic kinases is crucial for deciphering cancer development.

Purpose of the Study:

• To investigate the regulatory mechanisms by which oncogenic kinases impact the function and stability of the DLC1 tumor suppressor.
• To identify specific oncogenic kinases that directly interact with and modify DLC1.
• To elucidate the functional consequences of DLC1 dysregulation by oncogenic kinases in cancer cells.

Main Methods:

• Utilized in vitro kinase assays to assess direct phosphorylation of DLC1 by various oncogenic kinases.
• Employed Western blotting and immunoprecipitation to detect DLC1-kinase interactions and assess DLC1 protein levels.
• Performed cell-based assays, including proliferation and migration assays, to evaluate the functional impact of DLC1 regulation.

Main Results:

• Demonstrated that specific oncogenic kinases directly phosphorylate DLC1 at distinct sites.
• Observed that kinase-mediated DLC1 phosphorylation leads to its decreased stability and impaired tumor-suppressive activity.
• Showcased that inhibiting these oncogenic kinases restores DLC1 function and reduces cancer cell aggressiveness.

Conclusions:

• Oncogenic kinases actively regulate the tumor suppressor DLC1 through phosphorylation, contributing to cancer progression.
• Targeting these specific kinases could represent a viable therapeutic strategy to reactivate DLC1's tumor-suppressive functions.
• Further research into DLC1-kinase interactions may unveil novel biomarkers and therapeutic targets for various cancers.